AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 40 filers reported holding AXOVANT GENE THERAPIES LTD in Q2 2019. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $176,000 | +61.5% | 38,028 | -2.0% | 0.01% | +57.1% |
| Q2 2020 | $109,000 | +14.7% | 38,800 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $95,000 | -52.3% | 38,800 | 0.0% | 0.01% | -52.9% |
| Q4 2019 | $199,000 | -33.0% | 38,800 | -15.6% | 0.02% | -37.0% |
| Q3 2019 | $297,000 | +3.5% | 45,989 | 0.0% | 0.03% | +3.8% |
| Q2 2019 | $287,000 | – | 45,989 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,021,566 | $2,493,000 | 1.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,931,018 | $7,152,000 | 0.90% |
| Consonance Capital Management LP | 3,653,303 | $8,914,000 | 0.66% |
| Rubric Capital Management LP | 460,200 | $1,123,000 | 0.18% |
| Hudson Bay Capital Management LP | 1,350,000 | $3,294,000 | 0.08% |
| Ikarian Capital, LLC | 188,884 | $461,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 41,037 | $100,000 | 0.02% |
| Spark Investment Management LLC | 18,072 | $44,000 | 0.02% |
| Cable Hill Partners, LLC | 15,000 | $37,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,800 | $95,000 | 0.01% |